| |
 |
Editorial (Hot Topic: Recent Development of Molecular Targeted Anti-Cancer Agents)
 |
| |
|
pp.381-381 (1) Authors: Feng Liang, Yong Zeng |
| |
|
|
| |
|
Advances in the Systemic Treatment of Neuroendocrine Tumors in the Era of Molecular Therapy
|
| |
|
pp.382-388 (7) Authors: Roland Leung, Brian Lang, Hilda Wong, Joanne Chiu, Wan K. Yat, Tony Shek, Woo Y. Cho, Lo C. Yau, Thomas Yau |
| |
|
|
| |
|
Molecular Targeted Therapies in the Management of Head and Neck Squamous Cell Carcinoma: Recent Developments and Perspectives
|
| |
|
pp.389-402 (14) Authors: Alexandre Bozec, Frederic Peyrade, Gerard Milano |
| |
|
|
| |
|
Multifunctionalized Microbubbles for Cancer Diagnosis and Therapy
|
| |
|
pp.403-413 (11) Authors: Hao Li, Jianhao Wang, Gang Huang, Ping Wang, Rongqin Zheng, Chao Zhang, Qing Jiang |
| |
|
|
| |
|
Cytotoxicity and Cell Death Mechanisms Induced by a Novel Bisnaphthalimidopropyl Derivative against the NCI-H460 non-small Lung Cancer Cell Line
|
| |
|
pp.414-421 (8) Authors: Raquel T. Lima, Gemma A. Barron, Joanna A. Grabowska, Giovanna Bermano, Simranjeet Kaur, Nilanjan Roy, M. Helena Vasconcelos, Paul K.T. Lin |
| |
|
|
| |
|
Heterocyclic Chalcone Analogues as Potential Anticancer Agents
|
| |
|
pp.422-432 (11) Authors: Vikas Sharma, Vipin Kumar, Pradeep Kumar |
| |
|
|
| |
|
Biology and Medicinal Chemistry Approaches Towards Various Apoptosis Inducers
|
| |
|
pp.433-455 (23) Authors: Vivek K. Vyas, Chetan Chintha, Mitul R. Pandya |
| |
|
|
| |
|
Quinones Derived from Plant Secondary Metabolites as Anti-cancer Agents
|
| |
|
pp.456-463 (8) Authors: Jin-Jian Lu, Jiao-Lin Bao, Guo-Sheng Wu, Wen-Shan Xu, Ming-Qing Huang, Xiu-Ping Chen and Yi-Tao Wang |
| |
|
|
| |
|
Endocrine Therapy Resistance: Current Status, Possible Mechanisms and Overcoming Strategies
|
| |
|
pp.464-475 (12) Authors: Jinjia Chang, Weimin Fan |
| |
|
|
| |
|
Histone Deacetylase Inhibitors as Potential Therapeutic Agents for the Treatment of Malignant Mesothelioma
|
| |
|
pp.476-482 (7) Authors: Patroklos Katafygiotis, Constantinos Giaginis, Efstratios Patsouris, Stamatios Theocharis |
| |
|
|
| |
|
Treatment Directed to Signalling Molecules in Patients with Advanced Differentiated Thyroid Cancer
|
| |
|
pp.483-495 (13) Author: Jose M.G. Saez |
| |
|
|
| |
|
Redox-inactive Analogue of Tocotrienol as a Potential Anti-cancer Agent
|
| |
|
pp.496-501 (6) Authors: Tomohiro Yano, Ayami Sato, Miki Sekine, Nantiga Virgona, Masako Ota |
| |
|
|
| |
|
NADPH Oxidases NOXs and DUOXs as Putative Targets for Cancer Therapy
|
| |
|
pp.502-514 (13) Authors: Urbain Weyemi, Christophe E. Redon, Palak R. Parekh, Corinne Dupuy, William M. Bonner |
| |
|
|
| |
|
Targeting Heme for the Identification of Cytotoxic Agents
|
| |
|
pp.515-522 (8) Authors: Shiming Zhang, Hui Chen, Jessica Webster, Glenn S. Gerhard |
| |
|
|
| |
|
Human Skin-Derived Fibroblasts Acquire In Vitro Anti-Tumor Potential after Priming with Paclitaxel
|
| |
|
pp.523-530 (8) Authors: Augusto Pessina, Valentina Cocce, Arianna Bonomi, Loredana Cavicchini, Francesca Sisto, Maura Ferrari, Emilio Ciusani, Stefania Navone, Giovanni Marfia, Eugenio Parati, Giulio Alessandri |
| |
|
|
